Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-20

Clinical Trial Update: FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension [NA]

View source ↗

Summary

A clinical trial update indicates recruitment for a renal denervation therapy using the FlashPoint system under Columbus 3D mapping to treat hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FlashPoint Renal Denervation (renal denervation device)

Snippet

Sponsor: Shanghai Hongdian Medical CO., LTD | Conditions: Hypertension | NA | Status: RECRUITING